Prospective Study Open Access
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 447-452
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.447
Faecal incontinence and health related quality of life in inflammatory bowel disease patients: Findings from a tertiary care center in South Asia
Duminda Subasinghe, Navarathna Mudiyanselage Meththananda Navarathna, Dharmabandhu Nandadeva Samarasekera, Department of Surgery, Faculty of Medicine, University Surgical Unit, the National Hospital of Sri Lanka, Colombo 08, Sri Lanka
Author contributions: Subasinghe D, Navarathna NMM and Samarasekera DN were involved in study planning, data collection and analysis, and writing of the manuscript; all authors read and approved the final manuscript.
Institutional review board statement: This study was approved by the ethics review committee of the National Hospital of Sri Lanka.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors of this manuscript having no conflicts of Interest to disclose.
Data sharing statement: There is no additional data available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dharmabandhu Nandadeva Samarasekera, MBBS (Colombo), MS, MD (East Anglia), FRCS (Eng), FRCS (Edin), PG Cert MedEd (Dundee), Professor of Surgery and Head, Department of Surgery, Faculty of Medicine, University Surgical Unit, the National Hospital of Sri Lanka, Kynsey Road, Colombo 08, Sri Lanka. samarasekera58@yahoo.co.uk
Telephone: +94-77-5761000 Fax: +94-11-2691581
Received: December 9, 2015
Peer-review started: December 11, 2015
First decision: January 4, 2016
Revised: March 9, 2016
Accepted: April 14, 2016
Article in press: April 18, 2016
Published online: August 6, 2016
Processing time: 235 Days and 17.8 Hours

Abstract

AIM: To analyze the frequency and severity of faecal incontinence (FI) and its effect on the quality of life (QOL) in inflammatory bowel disease (IBD) patients.

METHODS: All patients who attended surgical and medical gastroenterology outpatient clinics in a tertiary care center with an established diagnosis of either ulcerative colitis (UC) or Crohn’s disease (CD) over a period of 10 mo were included in this study. Before enrollment into the study, the patients were explained about the study and informed consent was obtained. The patients with unidentified colitis were excluded. The data on demographics, disease characteristics, FI (Vaizey score), and quality of life (IBD-Q) were collected. Data were analyzed using SPSS version 21.

RESULTS: There were 184 patients (women = 101, 54.9%; UC = 153, 83.2%) with a female preponderance for UC (male/female ratio = 1:1.5) and a male preponderance for CD (male/female = 2:1). Forty-eight (26%) patients reported symptoms of FI. Among the patients with FI, 70.8% were women (n = 34) and 29.2% were men (n = 14) with an average age of 52.7 years (range, 20-78 years). Average age of onset of FI was 48.6 (range, 22-74) years. Ten percent (n = 5) reported regular FI. Incontinence to flatus was seen in 33.3% (n = 16), to liquid faeces in 56.2% (n = 27), to solid faeces in 6.2% (n = 3) and to all three in 4.1% (n = 2). Twenty-one percent (n = 10) complained of disruption of their physical and social activity. There was no association between FI and type of IBD. Significant associations were found between FI and age (P = 0.005) and gender (P < 0.001). QOL in our cohort of patients was significantly affected by FI.

CONCLUSION: In our study, nearly a quarter of patients reported FI. There was a significant correlation between FI and QOL. Therefore, enquiring about FI in IBD patients can lead to identification of this debilitating condition. This will enable early referral for continence care in this group of patients.

Key Words: Inflammatory bowel disease; Quality of life; Faecal incontinence; Crohn’s disease

Core tip: This was a prospective study involving 184 patients with inflammatory bowel disease (IBD). It was designed to analyze the frequency and severity of faecal incontinence (FI) and its effect on the quality of life (QOL) in IBD patients in a tertiary care center. In our study, nearly 25% of patients reported the symptoms of FI. There was a significant correlation between FI and QOL. Therefore, enquiring about FI in IBD patients can lead to identification of this debilitating condition.



INTRODUCTION

Faecal incontinence (FI) is defined as the involuntary passage of solid or liquid stools, which is a hygienic and social problem[1]. It is a devastating personal and social problem which causes emotional distress leading to social isolation and loss of self-confidence[2]. The prevalence rates of FI in the community vary between 2.2%-15% in adults[3-7]. It is widely accepted that many patients with anal incontinence do not seek medical advice, thus making the true prevalence uncertain. Therefore under-reporting is common due to social embarrassment[8,9].

FI can lead to social isolation. It also can adversely affect ability to maintain relationships, occupation and self-esteem aspects of the quality of life (QOL)[10,11]. Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic inflammatory conditions related to the gastrointestinal tract. There is a paucity of knowledge of FI in patients with inflammatory bowel disease (IBD), except in patients with fistulas and those who underwent restorative proctocolectomy with an ileal pouch[12]. FI is also known to be associated with vaginal delivery in women[13,14]. In addition, in both genders, FI can be associated with a range of pelvic floor disorders and perianal surgeries (e.g., haemorrhoidectomy and sphincterotomy)[15,16].

The only estimation of FI in IBD is from patients attending special clinics and the data from the Crohn’s and Colitis Foundation of the United Kingdom, and the incidence ranged from 22%-33.5%[17-19]. No previous study has reported on FI among patients with IBD in Sri Lanka or in South Asia.

Therefore, the main aim of this study was to determine the frequency and severity of FI, and its effect on QOL in IBD patients who presented to a tertiary care center in Sri Lanka, which is a South Asian country.

MATERIALS AND METHODS
Patients and methods

This study was conducted at the National Hospital of Sri Lanka, which is a tertiary care hospital. The patients were interviewed prospectively over a period of 10 mo. Before the interview, the patients were educated about the study and informed consent was obtained. All the patients who attended outpatient clinics with an established histological diagnosis of either UC or CD were included in the study. Diagnosis of IBD was made based on clinical, endoscopic, radiological and histological findings. Age younger than 18 years, lack of cooperation, diagnosed psychiatric illness, being too ill to participate, patients with neurological disorders and those with a previous traumatic anal sphincter injury were excluded from the study. The study was approved by the ethics review committee of the hospital.

All IBD patients were interviewed using an interviewer administered questionnaire, which consisted of two parts. The first part consisted of personal details of the patients including socio-demographic data, disease characteristics, management details and history. The second part of the questionnaire included FI severity (Vaizey score)[20] and quality of life (IBD-Q) score.

FI

FI was assessed based on Vaizey score with a four point scale: Never, rarely, sometimes, and regularly. Vaizey score was selected because it has shown high clinical validity and utility[20]. The Vaizey Incontinence questionnaire consists of seven questions. A score of 0 suggests no problems with bowel continence and a score of 24 suggests very severe problems with incontinence.

QOL

IBD-Q32 evaluates QOL in four main aspects (bowel symptoms, emotional health, systemic symptoms and social symptoms). Cumulative score reflects the overall QOL. For each aspect under specific category, score varies from one to seven. Score of one indicates very poor QOL and that of seven indicates excellent QOL. Total IBDQ score can range from 32 (very poor QOL) to 224 (perfect HRQOL).

Both IBDQ and Vaizey score were selected because of their simplicity and precision, which make those ideal for clinical practice to identify patients who require specialist help and in the clinical research setting to provide a sensitive measure of FI[20,21].

Statistical analysis

The associations between categorical data were examined using χ2 test. The association between categorical variables and IBDQ-32 scores was determined using Student’s t-test. Factors statistically significant in the univariate analysis were included in a multivariate regression model to examine their associations with FI score and QOL. The differences were considered significant when P≤ 0.05. Data were analyzed using SPSS (Version 21, Chicago, IL, United States).

RESULTS
Demographic and disease characteristics

There were 184 patients (M:F = 83:101) with a mean age of 44.5 (range, 20-78) years. The majority of patients (83.2%, n = 153) had UC. The mean duration of disease was 8.17 (range, 1-28) years, while 33.7% (n = 62) of patients had IBD for more than 10 years. The participation rate of our population was high (184/188 = 97.87%). The majority of UC patients were female, with a male to female ratio of 1:1.5. A male preponderance was noted in CD (male to female ratio = 2:1). None of our patients had a positive family history. Mean age at diagnosis for UC was 36.3 (range, 7-71) years. The patients with CD were diagnosed at a significantly younger age than UC patients (27.35 ± 10.22 years vs 38.14 ± 13.05 years, P < 0.0001). Peak age of onset was in the fourth decade for UC and in the third decade for CD (Table 1). Out of females (n = 101, UC = 91, CD = 10), the majority were unmarried (n = 55, UC = 47, CD = 8). Out of married females (n = 46), 25 had undergone lower segment caesarian sections and 10 had undergone vaginal deliveries, while 11 had no childbirth yet. There were no females with ongoing pregnancy in our sample.

Table 1 Demographic characteristics of the study population n (%).
Total IBDUCCD
Age at the diagnosis (yr)
≤ 102 (1.1)1 (0.7)1 (3.2)
11-1917 (9.2)13 (8.5)4 (12.9)
20-2942 (22.8)25 (16.3)17 (54.8)
30-3953 (28.8)49 (32.0)4 (12.9)
40-4939 (21.2)36 (23.5)3 (9.7)
50-5921 (11.4)19 (12.4)2 (6.5)
60-698 (4.3)8 (5.2)-
70-792 (1.1)2 (1.3)-
Gender
Male83 (45.1)62 (40.5)21 (67.7)
Female101 (54.9)91 (59.5)10 (32.3)
Education
Primary (Grade 1-5)40 (21.7)35 (22.9)5 (16.1)
Secondary (Grade 6-13)118 (64.1)101 (66.0)17 (54.8)
Higher (University or above)26 (14.1)17 (11.0)9 (29.0)
Employment
None72 (39.1)64 (41.8)8 (25.8)
Student11 (6.0)11 (7.2)-
Labourer63 (34.2)50 (32.7)13 (41.9)
Professional38 (20.7)28 (18.3)10 (32.3)
QOL

The mean of IBDQ-32 scores of enrolled patients was 94.28 (51 to 215). Mean IBDQ scores of bowel symptoms, systemic, emotional, social categories of IBDQ are shown in Table 2. The social symptom and systemic symptom categories had the lowest HRQOL scores (12.3 and 12.5, respectively).

Table 2 Descriptive statistics for the four domains and overall score of the IBDQ-32 and categories.
Minimum (Reference)Maximum (Reference)Mean
IBDQbowel105622.33
IBDQSystemic63412.5
IBDQEmotinal188434.87
IBDQSocial53512.3
IBDQTotal51 (32)215 (224)94.28

There was no significant difference between CD and UC, with regard to the mean IBDQ-32 (80.26 for CD and 79.52 for UC, P = 0.778) or mean Vaizey score (UC 13.79 vs CD 14.45, P = 0.629). Also, there was no significant difference in mean scores of bowel symptom (21.11 vs 22.39, P = 0.220), systemic (12.46 vs 12, P = 0.560) social (11.91 vs 11.10, P = 0.297) and emotional symptoms (34.04 vs 34.77, P = 0.607) between the two categories of UC and CD.

Determinants of QOL

Although females had a slightly higher mean IBDQ score (79.9 vs 79.34), it was not statistically significant (P = 0.769). In subgroup analysis, there was no significant difference in the four aspects of IBDQ categories (P > 0.05). Females had significantly higher incontinence scores than males (mean Vaizey score 79.9 vs 79.34, P < 0.05).

Twenty-six (14.1%) patients of the total study population underwent surgical treatment. In the UC group, 8.5% (n = 13) underwent surgical treatment, the commonest surgical procedure was restorative proctocolectomy (n = 12) and one patient underwent sigmoid colectomy. IBD patients who underwent surgery had significantly higher IBDQ bowel (23.48 vs 21, P < 0.05) and IBDQ total scores (81.83 vs 79.34, P < 0.05) compared to the patients who were on long-term medical management. However, the difference of incontinence scores was not significantly different between the two groups.

Mean IBDQ-emotional and IBDQ-social scores had significant association with the extent of colonic involvement by the disease. The mean total IBDQ scores did not show significant differences in relation to education level (P = 0.676), age (P = 0.343), duration (P = 0.884), extent of IBD (P = 0.92) or current symptoms of the disease (P = 0.3).

The relationships between psychosocial, clinical, and demographic variables and the overall score of IBDQ-32 are shown in Table 3.

Table 3 Details of surgical procedures for inflammatory bowel disease.
Surgical procedureIndicationn (%)
UC
Restorative proctocolectomy and ileoanal pouchSteriod resistance-7 Atypia on histology-4 Sigmoid colon cancer-112 (7.8)
Sigmoid colectomyStricture of sigmoid colon1 (0.7)
CD
Drainage and fistulectomyPerianal abscess and fistula1 (3.2)
Fistulectomy and repairRecurrent enterocutaneous fistula1 (3.2)
Incision and drainageR/Ischiorectal fossa abscess1 (3.2)
Repair of the fistulaEnrerocutaneous fistula2 (6.4)
R/hemicolectomy and ileo transverse anastomosisStrictures of the colon4 (12.9)
Total colectomy and ileostomyStrictures of colon2 (6.4)
Repair of the fistulaRecto vaginal fistula1 (3.2)
Strictureplasty, R/hemicolectomy and ileo transverseTwo long segment narrowings –distal ileum1 (3.2)
Anastomosismultiple narrowings > 10 in jejunum and proximal ileum and strictures of ascending colon-
FI vs QOL

The extent of colitis was significantly associated with the Vaizey scores (P = 0.002), where patients with distal colitis had higher scores. Association of total IBDQ and Vaizey score was statistically significant (P < 0.001). Pearson correlation was performed to determine the correlation between Vaizey score and components of QOL scores and total IBD-Q score. QOL scores for emotional and systemic components showed a weak association (Rho < 0.3), QOL score of social component showed a moderate association (Rho 0.3-0.7) and that of bowel symptoms showed a strong association (Rho > 0.7) (Table 4).

Table 4 Correlation between quality of life components and incontinence scores.
AssociationPearson correlation coefficient (Rho value)
IBDQbowel vs Vaizey score0.74
IBDQSystemic vs Vaizey score0.13
IBDQEmotinal vs Vaizey score0.09
IBDQSocial vs Vaizey score0.3
IBDQTotal vs Vaizey score0.61
DISCUSSION

It is noted that the incidence of IBD is increasing in the Asian population[22,23]. They are among the group of chronic disorders associated with periods of remission and unpredictable relapses. QOL measurement is especially pertinent in IBD, because it is a chronic disabling disease[24] which commonly occurs in early adulthood and hence affects all aspects of life, mainly physical, social and psychological. The peculiarities of chronic disease over acutely resolving conditions are that they often have a long-term negative effect on the emotional and social life, which are most of the time not visually apparent[25]. Feeling dirty and smelly following loss of bowel control, with resultant offensive body odours, unfulfilled potential in the work place and issues related to sexual relationships were the highly ranked concern in a survey of patients with IBD[26].

In addition, fear of loss of bowel control and its unpredictability can lead to a profound effect on the individual’s behaviour. In the majority of patients with IBD, this factor can lead to an avoidance of routine social events or impairment of daily activities[27,28]. Recent work by Daniel et al[27] and Hall et al[29] showed that these patients only attend places with toilet facilities or avoid public places all together.

Our results showed that IBD patients who underwent surgery for UC and CD had significantly higher IBDQ bowel (23.48 vs 21, P < 0.05) and IBDQ total scores (81.83 vs 79.34, P < 0.05) than those who was on long-term medical management. This may be due to the long-term symptom relief and avoidance of chronic medicine intake leading to more convenient life style. According to our results, higher Vaizey scores were associated with lower IBDQ scores (P < 0.001). This shows that the fear of anal incontinence and its unpredictability had a profound effect on the individual’s day-to-day activities. In our study, we found important variables significantly related with lower QOL, suggesting that HRQOL analysis has an important role in understanding the true impact of the disease on patients. QOL score of social component showed a moderate association (rho 0.3-0.7) and QOL of bowel symptom component showed a strong association (rho > 0.7) with FI. This shows the significant impact of incontinence on social activities.

In conclusion, FI has adverse effects on social, emotional and other aspects of QOL in patients with IBD. Given the availability of specialist FI interventions and support, we recommend that sensitive questioning regarding FI should be part of routine disease surveillance in the outpatient setting to cater for this unmet need.

COMMENTS
Background

Severity and impact of faecal incontinence (FI) on quality of life (QOL) of inflammatory bowel disease (IBD) are not widely investigated. In general FI has adverse effects on daily activities, hence on QOL. The current study was designed to evaluate the severity and frequency of FI and its effect on QOL in IBD patients presented to a tertiary care center in a South Asia country.

Research frontiers

This study has showed that FI has more adverse effects on social, emotional and other aspects of QOL in IBD. Given the availability of specialist FI interventions and support, the authors recommend that sensitive questioning regarding FI should be part of routine disease surveillance in the outpatient setting.

Innovations and breakthrough

Current literature suggests various strategies to improve the management and outcome of chronic diseases such as IBD. This study provides evidence on improvement QOL by considering the FI as an important aspect of the management.

Applications

This study has showed that FI correlates with HRQOL in IBD patients. Therefore, these aspects should be addressed to improve the management of these patients having this chronic disease.

Terminology

FI is defined as the involuntary passage of passage of solid or liquid stools, which is a social and hygienic problem. Ulcerative colitis/Crohn’s disease are chronic IBD affecting gastrointestinal tract.

Peer-review

A well-timed piece with pertinent clinical insight, and the information provided is relevant and could be interesting enough to warrant readers’ attention.

Footnotes

Specialty Type: Gastroenterology and Hepatology

Country of Origin: Sri Lanka

Peer-Review Report Classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C, C

Grade D (Fair): D

Grade E (Poor): 0

P- Reviewer: Flores C, Pastorelli L, Sandberg KC S- Editor: Gong ZM L- Editor: Wang TQ E- Editor: Lu YJ

References
1.  Norton C, Whitehead WE, Bliss DZ, Harari D, Lang J. Management of fecal incontinence in adults. Neurourol Urodyn. 2010;29:199-206.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 85]  [Cited by in F6Publishing: 84]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
2.  Crowell MD, Schettler VA, Lacy BE, Lunsford TN, Harris LA, DiBaise JK, Jones MP. Impact of anal incontinence on psychosocial function and health-related quality of life. Dig Dis Sci. 2007;52:1627-1631.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 31]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
3.  Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol. 1996;91:33-36.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Thomas TM, Egan M, Walgrove A, Meade TW. The prevalence of faecal and double incontinence. Community Med. 1984;6:216-220.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Macmillan AK, Merrie AE, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum. 2004;47:1341-1349.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 274]  [Cited by in F6Publishing: 236]  [Article Influence: 11.8]  [Reference Citation Analysis (0)]
6.  Perry S, Shaw C, McGrother C, Matthews RJ, Assassa RP, Dallosso H, Williams K, Brittain KR, Azam U, Clarke M. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut. 2002;50:480-484.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 404]  [Cited by in F6Publishing: 337]  [Article Influence: 15.3]  [Reference Citation Analysis (0)]
7.  Whitehead WE, Borrud L, Goode PS, Meikle S, Mueller ER, Tuteja A, Weidner A, Weinstein M, Ye W. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137:512-517, 517.e1-2.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Leigh RJ, Turnberg LA. Faecal incontinence: the unvoiced symptom. Lancet. 1982;1:1349-1351.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 197]  [Cited by in F6Publishing: 189]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
9.  Bartlett L, Nowak M, Ho YH. Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods. Tech Coloproctol. 2007;11:251-257.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 27]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
10.  Deutekom M, Terra MP, Dobben AC, Dijkgraaf MG, Baeten CG, Stoker J, Bossuyt PM. Impact of faecal incontinence severity on health domains. Colorectal Dis. 2005;7:263-269.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 50]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
11.  Bartlett L, Nowak M, Ho YH. Impact of fecal incontinence on quality of life. World J Gastroenterol. 2009;15:3276-3282.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 79]  [Cited by in F6Publishing: 74]  [Article Influence: 4.9]  [Reference Citation Analysis (0)]
12.  Wuthrich P, Gervaz P, Ambrosetti P, Soravia C, Morel P. Functional outcome and quality of life after restorative proctocolectomy and ileo-anal pouch anastomosis. Swiss Med Wkly. 2009;139:193-197.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Nichols CM, Ramakrishnan V, Gill EJ, Hurt WG. Anal incontinence in women with and those without pelvic floor disorders. Obstet Gynecol. 2005;106:1266-1271.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 27]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
14.  Chin K. Obstetrics and fecal incontinence. Clin Colon Rectal Surg. 2014;27:110-112.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
15.  Norton C. Faecal incontinence in adults. 1: Prevalence and causes. Br J Nurs. 1996;5:1366-1368, 1370-1374.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Lunniss PJ, Gladman MA, Hetzer FH, Williams NS, Scott SM. Risk factors in acquired faecal incontinence. J R Soc Med. 2004;97:111-116.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 43]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
17.  Enck P, Bielefeldt K, Rathmann W, Purrmann J, Tschöpe D, Erckenbrecht JF. Epidemiology of faecal incontinence in selected patient groups. Int J Colorectal Dis. 1991;6:143-146.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 80]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
18.  Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19:1450-1462.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 53]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
19.  Norton C, Dibley LB, Bassett P. Faecal incontinence in inflammatory bowel disease: associations and effect on quality of life. J Crohns Colitis. 2013;7:e302-e311.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 76]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
20.  Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44:77-80.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 963]  [Cited by in F6Publishing: 942]  [Article Influence: 37.7]  [Reference Citation Analysis (1)]
21.  Olopade FA, Norman A, Blake P, Dearnaley DP, Harrington KJ, Khoo V, Tait D, Hackett C, Andreyev HJ. A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br J Cancer. 2005;92:1663-1670.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 87]  [Cited by in F6Publishing: 91]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
22.  Yang SK, Hong WS, Min YI, Kim HY, Yoo JY, Rhee PL, Rhee JC, Chang DK, Song IS, Jung SA. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol. 2000;15:1037-1042.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 140]  [Cited by in F6Publishing: 120]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
23.  Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85-S93.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 165]  [Cited by in F6Publishing: 171]  [Article Influence: 7.1]  [Reference Citation Analysis (0)]
24.  Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289-297.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 654]  [Cited by in F6Publishing: 715]  [Article Influence: 51.1]  [Reference Citation Analysis (0)]
25.  Pizzi LT, Weston CM, Goldfarb NI, Moretti D, Cobb N, Howell JB, Infantolino A, Dimarino AJ, Cohen S. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47-52.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 123]  [Cited by in F6Publishing: 139]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
26.  de Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH, McLeod R, Cohen Z. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001;96:1816-1821.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 57]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
27.  Daniel JM. Young adults’ perceptions of living with chronic inflammatory bowel disease. Gastroenterol Nurs. 2002;25:83-94.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 43]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
28.  Dudley-Brown S. Living with ulcerative colitis. Gastroenterol Nurs. 1996;19:60-64.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 22]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
29.  Hall NJ, Rubin GP, Dougall A, Hungin AP, Neely J. The fight for ‘health-related normality’: a qualitative study of the experiences of individuals living with established inflammatory bowel disease (ibd). J Health Psychol. 2005;10:443-455.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 89]  [Cited by in F6Publishing: 89]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]